Thursday, January 20, 2005 6:12:34 PM
negatives? could also be:
MDT patent lawsuits
new diagnostic technology that makes MRI obsolete
competing products from well-heeled device manufacturers
but most of all the many things we aren't thinking of.
small company, big opportunity
I like the mgmt team, the advisory board, and the many different product lines they are pursuing. They will have an agreement with BSX, but when and for what products? What will BSX want exclusivity on, and what did Biophan have to give up for the honor? I think one reason the negotiations are dragging along is that BSX wants exclusivity and Biophan wants "industry standard", which to me means having their solutions on everybody's medical devices and such. Could be a big sticking point.
We might see the first deals announced that do not include BSX, and for smaller fees or royalties than might be expected, but I believe we will see something soon, perhaps the contrast agents.
jmho
b9
"watch yer keester"
posts are my opinion only and are not a substitute for doing your own research
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM